Neil E Stahl

This inventor holds 53 USPTO granted patents and 14 published patent applications, plus 10 CIPO patents and 4 EPO patents, primarily in Antibody Therapeutics. Top assignees: Regeneron Pharmaceuticals, Inc., St. Jude Children's Research Hospital, University of California. Active years: 1994-2025.

USPTO Granted Patents = 53 (Patent Applications = 14)

% Patents Active = 92.5

CIPO Patents = 10 (Patent Applications = 8)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.6

ph-index = 14

Forward Citations = 608(Granted Patents)

Forward Citations (Not Self Cited) = 560(Dec 10, 2025)

Location History:

S. Salem, NY (US) (1994)
Carmel, NY (US) (1995 - 2023)

Company Filing History:

51 out of 1,477

Regeneron Pharmaceuticals, Inc.

patents

1 out of 281

St. Jude Children's Research Hospital

patents

1 out of 15,988

University of California

patents

4. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-SARS-CoV-2

VEGF Traps

Ebola Virus

IL-4R Inhibitor

Cytokine Traps

Anemia Treatment

High Affinity Fusion Proteins

Secreted Proteins

Receptor Antagonists

Therapeutic Methods

Morphogenic Protein

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459991 - Compositions and methods for using bispecific antibodies to bind complement and a target antigen (2025-11-04),

2. 12325752 - Immunoglobulin proteins that bind to NPR1 agonists (2025-06-10),

3. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2025-03-18),

4. 12152067 - Human antibodies to ebola virus glycoprotein (2024-11-26),

5. 12103960 - VEGF traps and mini-traps and methods for treating ocular disorders and cancer (2024-10-01),

6. 11732030 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2023-08-22),

7. 11530255 - Human antibodies to Ebola virus glycoprotein (2022-12-20),

8. 11485788 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor (2022-11-01),

9. 10975139 - Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments (2021-04-13),

10. 10954289 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2021-03-23),

11. 10829544 - Human antibodies to Ebola virus glycoprotein (2020-11-10),

12. 10787501 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments (2020-09-29),

13. 10676530 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor (2020-06-09),

14. 10669341 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor (2020-06-02),

15. 10598669 - Isolating cells expressing secreted proteins (2020-03-24),

Title: Neil E Stahl - Pioneering Inventor from Carmel, NY

Introduction: Neil E Stahl is a renowned inventor hailing from Carmel, NY, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Neil E Stahl holds several patents in diverse areas such as technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Neil E Stahl has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many around the world.

Collaborations: Neil E Stahl has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Neil E Stahl's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, leaving a lasting impact on the world of inventions.